Works matching DE "SALMETEROL"

Results: 147

Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD).

Published in:

Emergency Medicine International, 2022, p. 1, doi. 10.1155/2022/2593740

By:

Mills, Hilla;
Acquah, Ronald;
Tang, Nova;
Cheung, Luke;
Klenk, Susanne;
Glassen, Ronald;
Pirson, Magali;
Albert, Alain;
Hoang, Duong Trinh;
Van, Thang Nguyen

Publication type:

Article

Chronic Obstructive Pulmonary Disease.

Published in:

MEDSURG Nursing, 2020, v. 29, n. 5, p. 348

By:

Frazer, Cynthia A.

Publication type:

Article

Salmeterol, a Long-Acting β2-Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis.

Published in:

2017

By:

Sharma, Monika;
Patterson, Lindsay;
Chapman, Elisha;
Flood, Patrick M.

Publication type:

journal article

Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol.

Published in:

Jornal de Pediatria, 2019, v. 95, n. 1, p. 69, doi. 10.1016/j.jped.2017.10.008

By:

Jentzsch, Nulma S.;
Silva, Gabriela C. G.;
Mendes, Guilherme M. S.;
Brand, Paul L. P.;
Camargos, Paulo

Publication type:

Article

Observation on effect of continuous health education for improving seretide treatment compliance of COPD patients in stable stage.

Published in:

Chinese Nursing Research, 2015, v. 29, n. 9C, p. 3397, doi. 10.3969/j.issn.1009-6493.2015.27.026

By:

Huang Jingming;
Zong Meirong;
Qiu Yuhua

Publication type:

Article

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator.

Published in:

European Journal of Health Economics, 2012, v. 13, n. 4, p. 379, doi. 10.1007/s10198-012-0392-9

By:

Neyt, Mattias;
Den Bruel, Ann

Publication type:

Article

Molecular Dynamic Study of Mechanism Underlying Nature of Molecular Recognition and the Role of Crosslinker in the Synthesis of Salmeterol-Targeting Molecularly Imprinted Polymer for Analysis of Salmeterol Xinafoate in Biological Fluid.

Published in:

Molecules, 2022, v. 27, n. 11, p. 3619, doi. 10.3390/molecules27113619

By:

Suryana, Shendi;
Mutakin, Mutakin;
Rosandi, Yudi;
Hasanah, Aliya Nur

Publication type:

Article

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization.

Published in:

Molecules, 2020, v. 25, n. 17, p. 3888, doi. 10.3390/molecules25173888

By:

Ainali, Nina Maria;
Xanthopoulou, Eleftheria;
Michailidou, Georgia;
Zamboulis, Alexandra;
Bikiaris, Dimitrios N.;
Mohyeldin, Mohamed Samir

Publication type:

Article

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler ® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study.

Published in:

Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1159, doi. 10.3390/jpm11111159

By:

Steiropoulos, Paschalis;
Tryfon, Stavros;
Kyriakopoulos, Christos;
Bartziokas, Konstantinos;
Kostikas, Konstantinos

Publication type:

Article

A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 1, p. 21, doi. 10.1111/1440-1681.12683

By:

Inoue, Hideki;
Niimi, Akio;
Matsumoto, Hisako;
Ito, Isao;
Oguma, Tsuyoshi;
Otsuka, Kojiro;
Takeda, Tomoshi;
Nakaji, Hitoshi;
Tajiri, Tomoko;
Iwata, Toshiyuki;
Nagasaki, Tadao;
Mishima, Michiaki

Publication type:

Article

Crystal structure of salmeterol xinafoate form I (Serevent®Diskus®), (C25H37NO4)(C11H8O3).

Published in:

Powder Diffraction, 2015, v. 30, n. 4, p. 333, doi. 10.1017/S0885715615000743

By:

Kaduk, James A.;
Zhong, Kai;
Gindhart, Amy M.;
Blanton, Thomas N.

Publication type:

Article

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease.

Published in:

Clinical Medicine Insights: Circulatory, Respiratory & Pulmonary Medicine, 2018, n. 12, p. 1, doi. 10.1177/1179548418771702

By:

Hideki Yasui;
Naoki Inui;
Tomoyuki Fujisawa;
Masato Karayama;
Noriyuki Enomoto;
Yutaro Nakamura;
Shigeki Kuroishi;
Hisano Ohba;
Koshi Yokomura;
Jun Sato;
Masaki Sato;
Naoki Koshimizu;
Mikio Toyoshima;
Takashi Yamada;
Masafumi Masuda;
Toshihiro Shirai;
Takafumi Suda

Publication type:

Article

Inhaled Fluticasone-Salmeterol Better Than Fluticasone Alone for Moderate to Severe Asthma.

Published in:

2016

By:

EBELL, MARK H.

Publication type:

journal article

Should Salmeterol Be Used for Long-term Asthma Control?

Published in:

American Family Physician, 2015, v. 91, p. 1

By:

CAYLEY JR., WILLIAM E.

Publication type:

Article

Approval of Generic Fluticasone Propionate/Salmeterol Xinafoate Dry Powder Inhalers in the US: A Difficult Exercise in Regulatory Science.

Published in:

Pharmaceutical Medicine, 2014, v. 28, n. 4, p. 169, doi. 10.1007/s40290-014-0065-3

By:

Fuglsang, Anders

Publication type:

Article

The INCA™ (Inhaler Compliance Assessment™): A comparison with established measures of adherence.

Published in:

Psychology & Health, 2017, v. 32, n. 10, p. 1266, doi. 10.1080/08870446.2017.1290243

By:

Moran, Catherine;
Doyle, Frank;
Sulaiman, Imran;
Bennett, Kathleen;
Greene, Garrett;
Molloy, Gerard J.;
Reilly, Richard B.;
Costello, Richard W.;
Mellon, Lisa

Publication type:

Article

Treatment Adherence and Health Status of Patients With COPD Under Treatment With Salmeterol/Fluticasone via the Elpenhaler® Device: The AHEAD Study.

Published in:

Clinical Respiratory Journal, 2024, v. 18, n. 7, p. 1, doi. 10.1111/crj.13803

By:

Exarchos, Konstantinos P.;
Hillas, Georgios;
Steiropoulos, Paschalis;
Papanastasiou, Polyanthi;
Gogali, Athena;
Kostikas, Konstantinos

Publication type:

Article

Would this long-acting bronchodilator be better for your patient?

Published in:

2012

By:

Gwynne, Mark;
Mounsey, Anne

Publication type:

Case Study

Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.

Published in:

2017

By:

Bousquet, Jean;
Barnes, Neil;
Gibbs, Michael;
Gul, Nadeem;
Tomkins, Susan A.;
Xin Zhou;
Young-Joo Cho;
Hae-Sim Park;
Busse, William;
Nanshan Zhong;
Zhou, Xin;
Cho, Young-Joo;
Park, Hae-Sim;
Zhong, Nanshan

Publication type:

journal article

Alternative to traditional noninvasive ventilation using a modified snorkel mask in a patient with SARS-COV2: A case report.

Published in:

Canadian Journal of Respiratory Therapy, 2021, v. 57, p. 18, doi. 10.29390/cjrt-2020-039

By:

Montalvo, Raul;
Castro, Eyner;
Chavez, Alvaro

Publication type:

Article

Sinobronchial syndrome treated as intractable asthma.

Published in:

2018

By:

Suzuki, Ryohei;
Sugimura, Kengo;
Akashi, Kenichi;
Katsunuma, Toshio

Publication type:

Case Study

The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler ® in COPD Patients in the Daily Clinical Practice.

Published in:

Applied Sciences (2076-3417), 2022, v. 12, n. 23, p. 12142, doi. 10.3390/app122312142

By:

Doniec, Zbigniew;
Olszanecka-Glinianowicz, Magdalena;
Hantulik, Piotr;
Almgren-Rachtan, Agnieszka;
Chudek, Jerzy

Publication type:

Article

Tiotropium/Olodaterol: A Review in COPD.

Published in:

Drugs, 2019, v. 79, n. 9, p. 997, doi. 10.1007/s40265-019-01133-w

By:

Blair, Hannah A.

Publication type:

Article

Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD).

Published in:

2024

By:

International, Emergency Medicine

Publication type:

Correction Notice

ASTHMA; COMPARISON OF SALMETEROL /FLUTICASONE PROPIONATE AND FORMOTEROL / BUDESONIDE IN PERSISTENT ASTHMA.

Published in:

Professional Medical Journal, 2017, v. 24, n. 11, p. 1749, doi. 10.17957/TPMJ/17.4443

By:

Abdullah, Muhammad;
Ahmed, Zaheer;
Fareed, Hassan

Publication type:

Article

Steroid-induced Ischemic Pancolitis.

Published in:

2017

By:

Akar, Mustafa;
Koseoglu, Huseyin;
Solakoglu, Tevfik;
Kosker, Tugba;
Buyukasik, Naciye;
Ersoy, Osman

Publication type:

Case Study

Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.

Published in:

Expert Review of Clinical Pharmacology, 2013, v. 6, n. 5, p. 503, doi. 10.1586/17512433.2013.828419

By:

Molimard, Mathieu;
D'Andrea, Peter

Publication type:

Article

Randomized, Double‐Blind, Crossover, Clinical‐End‐Point Pilot Study to Examine the Use of Exhaled Nitric Oxide as a Bioassay for Dose Separation of Inhaled Fluticasone Propionate.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 4, p. 448, doi. 10.1002/jcph.1043

By:

Weiler, John M.;
Sorkness, Christine A.;
Hendeles, Leslie;
Nichols, Sara;
Zhu, Yaping

Publication type:

Article

Evaluation of a Scenario in Which Estimates of Bioequivalence Are Biased and a Proposed Solution: tlast (Common).

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 7, p. 794, doi. 10.1002/jcph.663

By:

Fisher, Dennis;
Kramer, William;
Burmeister Getz, Elise

Publication type:

Article

An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease.

Published in:

Journal of Clinical Pharmacology, 2012, v. 52, n. 3, p. 416, doi. 10.1177/0091270010397050

By:

Lomas, David A.;
Lipson, David A.;
Miller, Bruce E.;
Willits, Lisa;
Keene, Oliver;
Barnacle, Helen;
Barnes, Neil C.;
Tal-Singer, Ruth

Publication type:

Article

PGE2 Desensitizes β-Agonist Effect on Human Lung Fibroblast-Mediated Collagen Gel Contraction through Upregulating PDE4.

Published in:

Mediators of Inflammation, 2013, v. 2013, p. 1, doi. 10.1155/2013/145197

By:

Qiuhong Fang;
Yingmin Ma;
Jing Wang;
Michalski, Joel;
Rennard, Stephen I.;
Xiangde Liu

Publication type:

Article

Chronic Digoxin Toxicity Leading to Institutionalization of an Elderly Woman.

Published in:

2022

By:

Nix, Kimberley;
Radu, Luiza;
Zou, Jason;
Vlasschaert, Meghan E. O.

Publication type:

Case Study

Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Published in:

COPD: Journal of Chronic Obstructive Pulmonary Disease, 2024, v. 21, n. 1, p. 1, doi. 10.1080/15412555.2024.2328708

By:

Shang, Nan;
Liu, Yang;
Jin, Yueping

Publication type:

Article

五运六气膏方对慢性阻塞性肺疾病西北寒燥证患者肺功能及炎症状态的影响.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2023, v. 23, n. 5, p. 552, doi. 10.14009/j.issn.1672-2124.2023.05.010

By:

李英;
刘艳丽;
范佳;
赵洪霄

Publication type:

Article

孟鲁司特钠片联合沙美特罗替卡松吸入气雾剂治疗老年中重度支气管哮喘有效性和安全性的系统评价.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2021, n. 10, p. 1227, doi. 10.14009/j.issn.1672-2124.2021.10.019

By:

郑子恢;
潘慧杰;
张亚同;
马琳;
李文英;
原涵;
金鹏飞

Publication type:

Article

Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 2, p. 204, doi. 10.1111/j.1365-2710.2011.01285.x

By:

Wang, J.;
Nie, B.;
Xiong, W.;
Xu, Y.

Publication type:

Article

Uncovering the regional localization of inhaled salmeterol retention in the lung.

Published in:

Drug Delivery, 2018, v. 25, n. 1, p. 838, doi. 10.1080/10717544.2018.1455762

By:

Bäckström, Erica;
Hamm, Gregory;
Nilsson, Anna;
Fihn, Britt-Marie;
Strittmatter, Nicole;
Andrén, Per;
Goodwin, Richard J. A.;
Fridén, Markus

Publication type:

Article

Uncovering the regional localization of inhaled salmeterol retention in the lung.

Published in:

Drug Delivery, 2018, v. 25, n. 1, p. 838, doi. 10.1080/10717544.2018.1455762

By:

Bäckström, Erica;
Hamm, Gregory;
Nilsson, Anna;
Fihn, Britt-Marie;
Strittmatter, Nicole;
Andrén, Per;
Goodwin, Richard J. A.;
Fridén, Markus

Publication type:

Article

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?

Published in:

Drug Delivery, 2017, v. 24, n. 1, p. 1395, doi. 10.1080/10717544.2017.1378937

By:

Muraki, Masato;
Gose, Kyuya;
Hanada, Soichiro;
Sawaguchi, Hirochiyo;
Tohda, Yuji

Publication type:

Article

Video education versus face-to-face education on inhaler technique for patients with well-controlled or partly-controlled asthma: A phase IV, open-label, non-inferiority, multicenter, randomized, controlled trial.

Published in:

PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0197358

By:

Park, Hye Jung;
Byun, Min Kwang;
Kwon, Jae-Woo;
Kim, Woo Kyung;
Nahm, Dong-Ho;
Lee, Myung-Goo;
Lee, Sang-Pyo;
Lee, Sook Young;
Lee, Ji-Hyun;
Jeong, Yi Yeong;
Cho, You Sook;
Choi, Jeong-Hee;
Choi, Byoung Whui

Publication type:

Article

THE EFFECT OF LOW-DOSE INHALED FLUTICASONE PROPIONATE ON FRACTIONAL EXHALED NITRIC OXIDE IN ASTHMATIC PEDIATRIC PATIENTS WITH AND WITHOUT ALLERGIC RHINITIS.

Published in:

Acta Poloniae Pharmaceutica, 2022, v. 79, n. 3, p. 431, doi. 10.32383/appdr/152261

By:

BIESIADECKI, MAREK;
GALINIAK, SABINA;
RACHEL, MARTA;
AEBISHER, DAVID

Publication type:

Article

Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial.

Published in:

Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 3, p. 223, doi. 10.1002/cpt.373

By:

Burmeister Getz, E;
Carroll, KJ;
Jones, B;
Benet, LZ

Publication type:

Article

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids.

Published in:

2020

By:

Huang, Tsan-Ming;
Kuo, Kuan-Chih;
Wang, Ya-Hui;
Wang, Cheng-Yi;
Lai, Chih-Cheng;
Wang, Hao-Chien;
Chen, Likwang;
Yu, Chong-Jen;
On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE);
Perng, Diahn-Warng;
Cheng, Shih-Lung;
Hsu, Jeng-Yuan;
Hsu, Wu-Huei;
Tsai, Ying-Huang;
Hsiue, Tzuen-Ren;
Lin, Meng-Chih;
Lin, Hen-I;
Chang, Yeun-Chung;
Yang, Ueng-Cheng;
Lin, Cing-Syong

Publication type:

journal article

Research roundup: December 2016.

Published in:

Nurse Prescribing, 2016, v. 14, n. 12, p. 582, doi. 10.12968/npre.2016.14.12.582

By:

Greener, Mark

Publication type:

Article

Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2012, v. 39, n. 6, p. 619, doi. 10.1007/s10928-012-9274-0

By:

Nielsen, Jace;
Hutmacher, Matthew;
Cleton, Adriaan;
Martin, Steven;
Ribbing, Jakob

Publication type:

Article

A highly enantioselective synthesis of (R)-salmeterol using a chiral auxiliary.

Published in:

Journal of Chemical Research, 2016, v. 40, n. 9, p. 564, doi. 10.3184/174751916X14719559894647

By:

Jiang, Lijue;
Lin, Chenggang;
Qiu, Yinhua;
Quan, Xu;
Zhu, Jing;
Shi, Haijian

Publication type:

Article

Implementation of a Metered-Dose Inhaler to Dry-Powder Inhaler National Formulary Transition.

Published in:

JAMA Network Open, 2024, v. 7, n. 12, p. e2449234, doi. 10.1001/jamanetworkopen.2024.49234

By:

Rabin, Alexander S.;
Weinstein, Julien B.;
Whittington, Taylor N.;
Hogan, Cainnear K.;
Khachikian, Deborah;
Seelye, Sarah M.;
Prescott, Hallie C.

Publication type:

Article

Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.

Published in:

Current Medical Research & Opinion, 2014, v. 30, n. 7, p. 1427, doi. 10.1185/03007995.2014.908828

By:

Ismaila, A.;
Corriveau, D.;
Vaillancourt, J.;
Parsons, D.;
Dalal, A.;
Su, Z.;
Sampalis, J.S.

Publication type:

Article

Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.

Published in:

Current Medical Research & Opinion, 2014, v. 30, n. 7, p. 1417, doi. 10.1185/03007995.2014.908827

By:

Ismaila, A.;
Corriveau, D.;
Vaillancourt, J.;
Parsons, D.;
Stanford, R.;
Su, Z.;
Sampalis, J. S.

Publication type:

Article

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β2-adrenergic polymorphisms.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 4, p. 1011, doi. 10.1185/03007990902805981

By:

Yancey, Steven W.;
Klotsman, Michael;
Ortega, Hector G.;
Edwards, Lisa D.;
Anderson, Wayne H.

Publication type:

Article